Impact of the Trough Level of Calcineurin Inhibitor on the Prevalence of Donor-Specific Human Leukocyte Antigen Antibodies During Long-Term Follow-Up After Pediatric Liver Transplantation: Antibody Strength and Complement-Binding Ability

Impact of the Trough Level of Calcineurin Inhibitor on the Prevalence of Donor-Specific Human Leukocyte Antigen Antibodies During Long-Term Follow-Up After Pediatric Liver Transplantation: Antibody Strength and Complement-Binding Ability

Background. In pediatric patients, long-term immunosuppression after liver transplantation (LT) is typically minimal. However, posttransplant donor-specific HLA antibodies (DSAs) may be prevalent under these conditions. Here, we evaluated the effects of minimized calcineurin inhibitor (CNI) on DSA d...

Full description

Bibliographic Details
Main Authors: Kazuaki Tokodai, MD, PhD, Shigehito Miyagi, MD, PhD, Chikashi Nakanishi, MD, PhD, Yasuyuki Hara, MD, PhD, Wataru Nakanishi, MD, PhD, Masafumi Goto, MD, PhD, Michiaki Unno, MD, PhD, Takashi Kamei, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2017-08-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000713

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000713

Similar Items